Skip to main content
Journal of the Canadian Association of Gastroenterology logoLink to Journal of the Canadian Association of Gastroenterology
. 2020 Mar 19;4(1):50. doi: 10.1093/jcag/gwaa008

Erratum

Avery Hughes 1,2, John K Marshall 3, Myla E Moretti 1,4, Wendy J Ungar 1,2
PMCID: PMC8215353  PMID: 34164604

“A Cost-Utility Analysis of Switching from Reference to Biosimilar Infliximab Compared to Maintaining Reference Infliximab in Adult Patients with Crohn’s Disease” by Avery Hughes, John K. Marshall, Myla E. Moretti, and Wendy J. Ungar. Journal of the Canadian Association of Gastroenterology 2020, doi: 10.1093/jcag/gwz045.

The author affiliations should be listed as follows:


Articles from Journal of the Canadian Association of Gastroenterology are provided here courtesy of Oxford University Press

RESOURCES